A number of studies indicate that NLRP3 inflammasome signaling is associated with carcinogenesis [102], and that inhibition of NLRP3 inflammasome can act as a cancer prevention strategy.Cancer medicine is entering a new era with nanotechnology-based therapies, and polymeric nanoparticles have become increasingly popular. Here, NLRP3 is linked to cancer.